Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

3articles mentioning drugs

6drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: NtproBNP ×

NtproBNP

This drug is selected. Its supporting articles are shown below.

Articles mentioning NtproBNP

3 articles · page 1 of 1

Prevalence and importance of coronary microvascular dysfunction in patients with heart failure and reduced or mildly reduced ejection fraction

openhrt · abstract · 2025-09-05 · 3 matching annotations

85.3%

hsTroponin-T NTproBNP heart failure coronary microvascular dysfunction HFrEF HFmrEF CMD

… independently associated with reduced GLS, higher NTproBNP and hsTroponin-T. Furthermore, in adjusted logistic regression analysis, lower L…

5-033 The addition of cardiac biomarker testing to annual primary care diabetes screening identifies undiagnosed cardiac disease in a substantial proportion of asymptomatic individuals with diabetes

heartjnl · abstract · 2025-08-13 · 2 matching annotations

77.6%

NT-proBNP hsTnI NTproBNP ischaemic heart disease heart failure Stage B HF hypertrophic cardiomyopathy diabetes atrial fibrillation hypertension+2 more

…/L, and 16 (6%) >1000 ng/L ( figure 1). Of the 45 patients with NT-proBNP >400 ng/L, 41 underwent echocardiography. Among them, 16 (39%) …

27 Real-world outcomes of cardiac resynchronisation therapy in a west of Ireland cohort: insights from a 7 year retrospective study

heartjnl · abstract · 2025-10-14 · 1 matching annotations

89.2%

NtproBNP University Hospital Galway HFREF Cardiac resynchronisation therapy

…. NYHA class improved to a median of 2 (IQR 1 to 2, p < 0.001). NtproBNP showed no statistically significant change (p = 0.165)Conclusio…